PLoS ONE (Jan 2013)

Mipu1, a novel direct target gene, is involved in hypoxia inducible factor 1-mediated cytoprotection.

  • Kangkai Wang,
  • Jian Lei,
  • Jiang Zou,
  • Hui Xiao,
  • Anlan Chen,
  • Xiaoliu Liu,
  • Ying Liu,
  • Lei Jiang,
  • Zihui Xiao,
  • Xianzhong Xiao

DOI
https://doi.org/10.1371/journal.pone.0082827
Journal volume & issue
Vol. 8, no. 12
p. e82827

Abstract

Read online

Mipu1 (myocardial ischemic preconditioning up-regulated protein 1), recently identified in our lab, is a novel zinc-finger transcription factor which is up-regulated during ischemic preconditioning. However, it is not clear what transcription factor contributes to its inducible expression. In the present study, we reported that HIF-1 regulates the inducible expression of Mipu1 which is involved in the cytoprotection of HIF-1α against oxidative stress by inhibiting Bax expression. Our results showed that the inducible expression of Mipu1 was associated with the expression and activation of transcription factor HIF-1 as indicated by cobalt chloride (CoCl2) treatment, HIF-1α overexpression and knockdown assays. EMSA and luciferase reporter gene assays showed that HIF-1α bound to the hypoxia response element (HRE) within Mipu1 promoter region and promoted its transcription. Moreover, our results revealed that Mipu1 inhibited the expression of Bax, an important pro-apoptosis protein associated with the intrinsic pathway of apoptosis, elevating the cytoprotection of HIF-1 against hydrogen peroxide (H2O2)-mediated injury in H9C2 cells. Our findings implied that Bax may be a potential target gene of transcription factor Mipu1, and provided a novel insight for understanding the cytoprotection of HIF-1 and new clues for further elucidating the mechanisms by which Mipu1 protects cell against pathological stress.